Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 38
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Blumberger, Daniel M. Barr, Mera S. and Daskalakis, Zafiris J. 2016. Neuromodulation in Psychiatry.

    Garg, Shobit Sinha, Vinod Kumar Tikka, Sai Krishna Mishra, Preeti and Goyal, Nishant 2016. The efficacy of cerebellar vermal deep high frequency (theta range) repetitive transcranial magnetic stimulation (rTMS) in schizophrenia: A randomized rater blind-sham controlled study. Psychiatry Research, Vol. 243, p. 413.

    Dlabac-de Lange, J. J. Bais, L. van Es, F. D. Visser, B. G. J. Reinink, E. Bakker, B. van den Heuvel, E. R. Aleman, A. and Knegtering, H. 2015. Efficacy of bilateral repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: results of a multicenter double-blind randomized controlled trial. Psychological Medicine, Vol. 45, Issue. 06, p. 1263.

    Dougall, Nadine Maayan, Nicola Soares-Weiser, Karla McDermott, Lisa M McIntosh, Andrew and Dougall, Nadine 2015. Cochrane Database of Systematic Reviews.

    Dunn, Walter and Marder, Stephen R. 2015. Novel Treatments of Psychosis. Current Behavioral Neuroscience Reports, Vol. 2, Issue. 2, p. 119.

    Quan, Wen Xiang Zhu, Xiao Lin Qiao, Hong Zhang, Wu Fang Tan, Shu Ping Zhou, Dong Feng and Wang, Xiang Qun 2015. The effects of high-frequency repetitive transcranial magnetic stimulation (rTMS) on negative symptoms of schizophrenia and the follow-up study. Neuroscience Letters, Vol. 584, p. 197.

    2015. Therapie Psychischer Erkrankungen.

    Lefaucheur, Jean-Pascal André-Obadia, Nathalie Antal, Andrea Ayache, Samar S. Baeken, Chris Benninger, David H. Cantello, Roberto M. Cincotta, Massimo de Carvalho, Mamede De Ridder, Dirk Devanne, Hervé Di Lazzaro, Vincenzo Filipović, Saša R. Hummel, Friedhelm C. Jääskeläinen, Satu K. Kimiskidis, Vasilios K. Koch, Giacomo Langguth, Berthold Nyffeler, Thomas Oliviero, Antonio Padberg, Frank Poulet, Emmanuel Rossi, Simone Rossini, Paolo Maria Rothwell, John C. Schönfeldt-Lecuona, Carlos Siebner, Hartwig R. Slotema, Christina W. Stagg, Charlotte J. Valls-Sole, Josep Ziemann, Ulf Paulus, Walter and Garcia-Larrea, Luis 2014. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clinical Neurophysiology, Vol. 125, Issue. 11, p. 2150.

    Prikryl, Radovan Ustohal, Libor Kucerova, Hana Prikrylova Kasparek, Tomas Jarkovsky, Jiri Hublova, Veronika Vrzalova, Michaela and Ceskova, Eva 2014. Repetitive transcranial magnetic stimulation reduces cigarette consumption in schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 49, p. 30.

    Shi, Chuan Yu, Xin Cheung, Eric F.C. Shum, David H.K. and Chan, Raymond C.K. 2014. Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis. Psychiatry Research, Vol. 215, Issue. 3, p. 505.

    2014. Therapie Psychischer Erkrankungen.

    Prikryl, Radovan Ustohal, Libor Prikrylova Kucerova, Hana Kasparek, Tomas Venclikova, Simona Vrzalova, Michaela and Ceskova, Eva 2013. A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: A double-blind trial. Schizophrenia Research, Vol. 149, Issue. 1-3, p. 167.

    Barr, Mera S. Farzan, Faranak Tran, Lisa C. Fitzgerald, Paul B. and Daskalakis, Zafiris J. 2012. A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia. Brain Stimulation, Vol. 5, Issue. 3, p. 337.

    Lefaucheur, J.-P. André-Obadia, N. Poulet, E. Devanne, H. Haffen, E. Londero, A. Cretin, B. Leroi, A.-M. Radtchenko, A. Saba, G. Thai-Van, H. Litré, C.-F. Vercueil, L. Bouhassira, D. Ayache, S.-S. Farhat, W.-H. Zouari, H.-G. Mylius, V. Nicolier, M. and Garcia-Larrea, L. 2011. Recommandations françaises sur l’utilisation de la stimulation magnétique transcrânienne répétitive (rTMS) : règles de sécurité et indications thérapeutiques. Neurophysiologie Clinique/Clinical Neurophysiology, Vol. 41, Issue. 5-6, p. 221.

    Leucht, Stephan Correll, Christoph U. and Kane, John M. 2011. Schizophrenia.

    Leucht, Stefan Heres, Stephan Kissling, Werner and Davis, John M. 2011. Evidence-based pharmacotherapy of schizophrenia. The International Journal of Neuropsychopharmacology, Vol. 14, Issue. 02, p. 269.

    Oh, So-Young and Kim, Yong-Ku 2011. Adjunctive treatment of bimodal repetitive transcranial magnetic stimulation (rTMS) in pharmacologically non-responsive patients with schizophrenia: A preliminary study. Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 35, Issue. 8, p. 1938.

    Rado, Jeffrey T. 2011. Management of Negative Symptoms in Schizophrenia. Psychiatric Annals, Vol. 41, Issue. 5, p. 265.

    Rado, Jeffrey T. 2011. Treatment of Negative Symptoms in Schizophrenia. Psychopharm Review, Vol. 46, Issue. 5, p. 33.

    Stanford, Arielle D. Corcoran, Cheryl Bulow, Peter Bellovin-Weiss, Sarah Malaspina, Dolores and Lisanby, Sarah H. 2011. High-Frequency Prefrontal Repetitive Transcranial Magnetic Stimulation for the Negative Symptoms of Schizophrenia. The Journal of ECT, Vol. 27, Issue. 1, p. 11.


High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study

  • G. HAJAK (a1), J. MARIENHAGEN (a1), B. LANGGUTH (a1), S. WERNER (a1), H. BINDER (a1) and P. EICHHAMMER (a1)
  • DOI:
  • Published online: 01 October 2004

Background. Repetitive transcranial magnetic stimulation (rTMS) of frontal brain regions is under study as a non-invasive method in the treatment of affective disorders. Recent publications provide increasing evidence that rTMS may be useful in treating schizophrenia. Results are most intriguing, demonstrating a reduction of negative symptoms following high-frequency rTMS. In this context, disentangling of negative and depressive symptoms is of the utmost importance when understanding specific rTMS effects on schizophrenic symptoms.

Method. Using a sham-controlled parallel design, 20 patients with schizophrenia were included in the study. Patients were treated with high-frequency 10 Hz rTMS over 10 days. Besides clinical ratings, ECD-SPECT (technetium-99 bicisate single photon emission computed tomography) imaging was performed before and after termination of rTMS treatment.

Results. High-frequency rTMS leads to a significant reduction of negative symptoms combined with a trend for non-significant improvement of depressive symptoms in the active stimulated group as compared with the sham stimulated group. Additionally, a trend for worsening of positive symptoms was observed in the actively treated schizophrenic patients. In both groups no changes in regional cerebral blood flow could be detected by ECD-SPECT.

Conclusions. Beneficial effects of high-frequency rTMS on negative and depressive symptoms were found, together with a trend for worsening positive symptoms in schizophrenic patients.

Corresponding author
Professor Göran Hajak, Department of Psychiatry and Psychotherapy, University of Regensburg, Universitaetsstrasse 84, 93042 Regensburg, Germany. (Email:
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *